https://protacsignals.com/inde....x.php/synthesis-as-w
Furthermore, auranofin paid down the burden of intracellular N. gonorrhoeae by over 99% outperforming the medication of choice ceftriaxone. Auranofin had been discovered more advanced than ceftriaxone in reducing the release of the pro-inflammatory cytokine IL-8 by endocervical cells contaminated with N. gonorrhoeae. Additionally, auranofin exhibited an extended post-antibiotic impact over 10 h, also failure to create resistant mutants. Overall, the existing